Learn more

GENOVIE AB

Overview
  • Total Patents
    54
  • GoodIP Patent Rank
    27,278
  • Filing trend
    ⇩ 71.0%
About

GENOVIE AB has a total of 54 patent applications. It decreased the IP activity by 71.0%. Its first patent ever was published in 2015. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are SOUTHWEST FOUND BIOMED RES, GEORG AUGUST UNIV GOETTINGEN STIFTUNG OEFFENTLICHEN RECHTS UNIVSMEDIZIN and SYSTEMIX INC.

Patent filings per year

Chart showing GENOVIE ABs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Jarvis Reagan Micheal 54
#2 Hill Ryan Edward 42
#3 Pase Luke Benjamin 42
#4 Thörn Magnus 12
#5 Uchtenhagen Hannes 1

Latest patents

Publication Filing date Title
AU2019301865A1 A cell surface tag exchange (CSTE) system for tracing and manipulation of cells during recombinase mediated cassette exchange integration of nucleic acid sequences to engineered receiver cells
EP3655532A1 A two-component vector library system for rapid assembly and diversification of full-length t-cell receptor open reading frames
EP3567050A1 A combined tandem- and dual manufacturing system for human antibody engineering operating with b-cell receptor presentation
US2020115432A1 An engineered two-part cellular device for discovery and characterisation of t-cell receptor interaction with cognate antigen
WO2018083318A1 A two-part device for t-cell receptor synthesis and stable genomic integration to tcr-presenting cells
CN109996813A For identifying and characterizing the multi-component system of the engineering of T cell receptor, T cell antigen and its functional interaction
US2019359934A1 An engineered multi-component system for identification and characterisation of t-cell receptors and t-cell antigens
EP3131561A1 Cd8+ regulatory t-cells for use in the treatment of inflammatory and autoimmune diseases
EP3131559A1 Cd8+ regulatory t-cells for use in the treatment of inflammatory disorders of the human gastrointestinal tract
EP3131560A1 Method for the identification of cd4+ regulatory t-cells for use in the treatment of inflammatory and autoimmune diseases
WO2015158855A1 Regulatory t-cells for use in the treatment of inflammatory disorders of the human gastrointestinal tract